Publications

• Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 31 Page(s): 347.e1 - 347.e17
  06/01/2025 Authors: Dvila Saldaa BJ; Schultz KR; Ramgopal A; Boiko JR; Beebe K; Carpenter PA; Chan SS; Paczesny S; Aguayo-Hiraldo P; Cuvelier GDE
• Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations.
  Transplant Cell Ther
  05/24/2025 Authors: Mehta RS; Schmidt G; Williams K; Patel SA; Schetelig J; Savani B; Askar M; Petersdorf E; Ringden O; Kanakry CG
• NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.
  Transplant Cell Ther
  05/21/2025 Authors: Lee SJ; Williams KM; Sarantopoulos S; Kitko CL; Cutler C; Pidala J; Hill GR; DeFilipp Z; Greinix HT; Wolff D
• Interpretation of Response in BOS-the Definitions Remain Key.
  Blood Adv
  05/01/2025 Authors: Williams KM; Lama VN; Cooke KR; Yanik GA
• Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 31 Page(s): 297.e1 - 297.e15
  05/01/2025 Authors: Khandelwal P; Fish JD; Gorfinkel L; Guilcher GMT; Howell J; Nishitani M; Nuechterlein B; Obeng E; Shah AJ; Cuvelier GDE
• Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.
  Transplant Cell Ther Volume: 31 Page(s): 224.e1 - 224.e13
  04/01/2025 Authors: Rotz SJ; Wiener L; Baker KS; Choi SW; Phelan R; Cuvelier GDE; Duncan C; Williams KM; Qayed M
• Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.
  Transplant Cell Ther Volume: 31 Page(s): 69.e1 - 69.e18
  02/01/2025 Authors: Bhatt NS; Harris AC; Gorfinkel L; Ibanez K; Tkaczyk ER; Mitchell SA; Albuquerque S; Schechter T; Pavletic S; Duncan CN
• 18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.
  Radiol Imaging Cancer Volume: 7 Page(s): e240096
  01/01/2025 Authors: Holter-Chakrabarty J; McNally L; Levine J; Ferrara J; Vesely SK; Kanakry CG; Garwe T; Han Z; Pandey M; Glover J
• Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
  Br J Haematol Volume: 206 Page(s): 368 - 371
  01/01/2025 Authors: Frost EL; Chonat S; Williams KM; Aumann W; Stevenson J; Yin J; Schniederjan M; Arnold S; Schoettler ML
• Incidence of bacterial blood stream infections in patients with acute GVHD.
  Bone Marrow Transplant Volume: 60 Page(s): 52 - 57
  01/01/2025 Authors: Wallis W; Gulbis AM; Wang T; Lee CJ; Sharma A; Williams KM; Nishihori T; Prestidge T; Gowda L; Byrne M
• Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.
  Lancet Child Adolesc Health Volume: 8 Page(s): 740 - 750
  10/01/2024 Authors: Kahn J; Brazauskas R; Bo-Subait S; Buchbinder D; Hamilton BK; Schoemans H; Abraham AA; Agrawal V; Auletta JJ; Badawy SM
• Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
  09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
• Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients-Beware Reliance on Schistocytes Alone.
  Transplant Cell Ther Volume: 30 Page(s): 818 - 820
  08/01/2024 Authors: Schoettler ML; Williams KM
• Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
  Br J Haematol Volume: 205 Page(s): 243 - 255
  07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
• Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.
  Blood Adv Volume: 8 Page(s): 1220 - 1233
  03/12/2024 Authors: Schoettler ML; Lehmann L; Kao P-C; Chen N; Jodele S; Chonat S; Williams KM; London WB; Duncan C; Dandoy C
• D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
  Am J Hematol Volume: 99 Page(s): 370 - 379
  03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
• Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
  03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
• Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
  Transplant Cell Ther Volume: 30 Page(s): 255 - 267
  03/01/2024 Authors: Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV
• OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
  PLoS One Volume: 19 Page(s): e0301281
  01/01/2024 Authors: Wilson EA; Woodbury A; Williams KM; Coopersmith CM
• Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
  12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
• Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
  Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
  11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
• Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
  Pediatr Blood Cancer Volume: 70 Page(s): e30606
  10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML
• Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
  Blood Adv Volume: 7 Page(s): 4395 - 4399
  08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
• VORINOSTAT FOR GVHD PROPHYLAXIS IN CHILDREN, ADOLESCENT, AND YOUNG ADULTS IS WELL-TOLERATED, ASSOCIATED WITH LOW INCIDENCE OF ACUTE GVHD, AND MAY REDUCE POST-TRANSPLANT COGNITIVE DIFFICULTIES
  Volume: 70 Page(s): S201 - S202
  06/01/2023 Authors: Lugt MV; Votruba K; Braun T; Churay T; Rozwadowski M; Yanik GA; Riwes M; Abusin G; Anand S; Kitko CL
• DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
  Volume: 70 Page(s): S214 - S215
  06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
• Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.
  Transplant Cell Ther Volume: 29 Page(s): 380.e1 - 380.e9
  06/01/2023 Authors: Knight TE; Ahn KW; Hebert KM; Atshan R; Wall DA; Chiengthong K; Rotz SJ; Fraint E; Rangarajan HG; Auletta JJ
• Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
  Blood Adv Volume: 7 Page(s): 1784 - 1795
  05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
• Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
  Leukemia Volume: 37 Page(s): 1006 - 1017
  05/01/2023 Authors: Boyiadzis M; Zhang M-J; Chen K; Abdel-Azim H; Abid MB; Aljurf M; Bacher U; Badar T; Badawy SM; Battiwalla M
• Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients.
  Leukemia Volume: 37 Page(s): 1173
  05/01/2023 Authors: Boyiadzis M; Zhang M-J; Chen K; Abdel-Azim H; Abid MB; Aljurf M; Bacher U; Badar T; Badawy SM; Battiwalla M
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
  Lancet Respir Med Volume: 11 Page(s): 329 - 340
  04/01/2023 Authors: Mayer-Hamblett N; Ratjen F; Russell R; Donaldson SH; Riekert KA; Sawicki GS; Odem-Davis K; Young JK; Rosenbluth D; Taylor-Cousar JL
• The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study.
  Bone Marrow Transplant Volume: 58 Page(s): 360 - 366
  04/01/2023 Authors: Ramanathan M; Kim S; He N; Chen M; Hematti P; Abid MB; Rotz SJ; Williams KM; Lazarus HM; Wirk B
• Fluorothymidine PET/CT Identifies a Case of Herpes Simplex Virus Esophagitis.
  Radiol Imaging Cancer Volume: 5 Page(s): e220141
  03/01/2023 Authors: Glover J; Nadig A; Vesely S; Neelakantan D; Williams KM; Holter-Chakrabarty J
• Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality.
  Front Oncol Volume: 13 Page(s): 1232621
  01/01/2023 Authors: Schoettler ML; Dandoy CE; Harris A; Chan M; Tarquinio KM; Jodele S; Qayed M; Watkins B; Kamat P; Petrillo T
• Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
  Transplant Cell Ther Volume: 29 Page(s): 45.e1 - 45.e8
  01/01/2023 Authors: Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J
• Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV Syndrome.
  J Pediatr Hematol Oncol Volume: 45 Page(s): e139 - e141
  01/01/2023 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann WK; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL
• Advances in Imaging of Inflammation, Fibrosis, and Cancer in the Gastrointestinal Tract.
  Int J Mol Sci Volume: 23
  12/17/2022 Authors: Harold KM; MacCuaig WM; Holter-Charkabarty J; Williams K; Hill K; Arreola AX; Sekhri M; Carter S; Gomez-Gutierrez J; Salem G
• Incidence and risk factors for graft failure in the modern era of cord blood transplantation.
  Vox Sang Volume: 117 Page(s): 1405 - 1410
  12/01/2022 Authors: Chakrabarty JH; Glover J; Schmidt S; Phan M; Bycko M; Duong Q; Vesely SK; O'Neal C; Robertson C; Davis C
• Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
  Transplant Cell Ther Volume: 28 Page(s): 696.e1 - 696.e7
  10/01/2022 Authors: Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM
• Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
  Transplant Cell Ther Volume: 28 Page(s): 426 - 445
  08/01/2022 Authors: Cuvelier GDE; Schoettler M; Buxbaum NP; Pinal-Fernandez I; Schmalzing M; Distler JHW; Penack O; Santomasso BD; Zeiser R; Angstwurm K
• Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients.
  Hepatol Commun Volume: 6 Page(s): 2210 - 2220
  08/01/2022 Authors: Yang AH; Han MAT; Samala N; Rizvi BS; Marchalik R; Etzion O; Wright EC; Patel R; Khan V; Kapuria D
• Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.
  ERJ Open Res Volume: 8
  07/01/2022 Authors: Glanville AR; Benden C; Bergeron A; Cheng G-S; Gottlieb J; Lease ED; Perch M; Todd JL; Williams KM; Verleden GM
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
  Transplant Cell Ther Volume: 28 Page(s): 264.e1 - 264.e9
  05/01/2022 Authors: Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE
• Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
  Blood Adv Volume: 6 Page(s): 2520 - 2534
  04/26/2022 Authors: Kinoshita H; Cooke KR; Grant M; Stanojevic M; Cruz CR; Keller M; Fortiz MF; Hoq F; Lang H; Barrett AJ
• Controversies and expectations for the prevention of GVHD: A biological and clinical perspective.
  Front Immunol Volume: 13 Page(s): 1057694
  01/01/2022 Authors: Watkins B; Williams KM
• Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR.
  Front Immunol Volume: 13 Page(s): 999298
  01/01/2022 Authors: Stanojevic M; Grant M; Vesely SK; Knoblach S; Kanakry CG; Nazarian J; Panditharatna E; Panchapakesan K; Gress RE; Holter-Chakrabarty J
• Noninfectious complications of hematopoietic cell transplantation.
  Hematology Am Soc Hematol Educ Program Volume: 2021 Page(s): 578 - 586
  12/10/2021 Authors: Williams KM
• Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy.
  Curr Opin Hematol Volume: 28 Page(s): 408 - 416
  11/01/2021 Authors: Schoettler M; Chonat S; Williams K; Lehmann L
• DYNAMIC CHANGES IN LIVER INJURY PATTERN PREDICTS HEPATIC GRAFT VERSUS HOST DISEASE IN CRITICAL ILLNESS
  Volume: 74 Page(s): 758A - 759A
  10/01/2021 Authors: Yang AH; Han MAT; Samala NR; Rizvi BS; Marchalik R; Etzion O; Wright EC; Patel R; Khan V; Kapuria D
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
  Transplant Cell Ther Volume: 27 Page(s): 817 - 835
  10/01/2021 Authors: Wolff D; Radojcic V; Lafyatis R; Cinar R; Rosenstein RK; Cowen EW; Cheng G-S; Sheshadri A; Bergeron A; Williams KM
• Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 27 Page(s): 759.e1 - 759.e8
  09/01/2021 Authors: Inamoto Y; Martin PJ; Onstad LE; Cheng G-S; Williams KM; Pusic I; Ho VT; Arora M; Pidala J; Flowers MED
• Checkpoint-blocked T cells checkmate AML.
  Blood Volume: 137 Page(s): 3155 - 3156
  06/10/2021 Authors: Williams KM
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.
  Transplant Cell Ther Volume: 27 Page(s): 452 - 466
  06/01/2021 Authors: Williams KM; Inamoto Y; Im A; Hamilton B; Koreth J; Arora M; Pusic I; Mays JW; Carpenter PA; Luznik L
• COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium.
  Transplant Cell Ther Volume: 27 Page(s): 474.e1 - 474.e3
  06/01/2021 Authors: Williams KM; Wilson PT; Silva-Palacios F; Kebbe J; LaBeaud AD; Agudelo H; Sidonio RF; Stowell SR; Josephson CD; Tarini BA
• A Pediatric Case of Transformed Mycosis Fungoides in a BRCA2 Positive Patient.
  J Pediatr Hematol Oncol Volume: 42 Page(s): e361 - e364
  07/01/2020 Authors: Gross AM; Turner J; Kirkorian AY; Okoye GA; Luca DC; Bornhorst M; Jacobs SS; Williams KM; Schore RJ
• The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
  Biol Blood Marrow Transplant Volume: 26 Page(s): 1137 - 1143
  06/01/2020 Authors: Schmidt S; Liu Y; Hu Z-H; Williams KM; Lazarus HM; Vij R; Kharfan-Dabaja MA; Ort G; Wiernik PH; Weisdorf D
• Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases.
  Blood Adv Volume: 4 Page(s): 2084 - 2094
  05/12/2020 Authors: Kahn JM; Brazauskas R; Tecca HR; Bo-Subait S; Buchbinder D; Battiwala M; Flowers MED; Savani BN; Phelan R; Broglie L
• Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
  JAMA Oncol Volume: 6 Page(s): 696 - 705
  05/01/2020 Authors: Stratton P; Battiwalla M; Tian X; Abdelazim S; Baird K; Barrett AJ; Cantilena CR; Childs RW; DeJesus J; Fitzhugh C
• Scientific Review Committees as part of institutional review of human participant research: Initial implementation at institutions with Clinical and Translational Science Awards.
  J Clin Transl Sci Volume: 4 Page(s): 115 - 124
  04/01/2020 Authors: Selker HP; Welch LC; Patchen-Fowler E; Breeze JL; Terrin N; Parajulee A; LeClair A; Naeim A; Marnocha R; Morelli Novak J
• Imaging haemopoietic stem cells and microenvironment dynamics through transplantation.
  Lancet Haematol Volume: 7 Page(s): e259 - e269
  03/01/2020 Authors: Williams KM; Chakrabarty JH
• Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
  Biol Blood Marrow Transplant Volume: 26 Page(s): 333 - 342
  02/01/2020 Authors: Zinter MS; Logan BR; Fretham C; Sapru A; Abraham A; Aljurf MD; Arnold SD; Artz A; Auletta JJ; Chhabra S
• Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
  Clin Infect Dis Volume: 69 Page(s): 1771 - 1779
  10/30/2019 Authors: Papanicolaou GA; Ustun C; Young J-AH; Chen M; Kim S; Woo Ahn K; Komanduri K; Lindemans C; Auletta JJ; Riches ML
• Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
  Bone Marrow Transplant Volume: 54 Page(s): 1254 - 1265
  08/01/2019 Authors: Ustun C; Young J-AH; Papanicolaou GA; Kim S; Ahn KW; Chen M; Abdel-Azim H; Aljurf M; Beitinjaneh A; Brown V
• GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
  Blood Adv Volume: 3 Page(s): 1441 - 1449
  05/14/2019 Authors: Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H
• Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant.
  JAMA Pediatr Volume: 173 Page(s): e190081
  05/01/2019 Authors: Parikh SH; Satwani P; Ahn KW; Sahr NA; Fretham C; Abraham AA; Agrawal V; Auletta JJ; Abdel-Azim H; Copelan E
• Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally.
  Bone Marrow Transplant Volume: 54 Page(s): 383 - 392
  03/01/2019 Authors: Hakim A; Cooke KR; Pavletic SZ; Khalid M; Williams KM; Hashmi SK
• Critical testing and parameters for consideration when manufacturing and evaluating tumor-associated antigen-specific T cells.
  Cytotherapy Volume: 21 Page(s): 278 - 288
  03/01/2019 Authors: Tanna JG; Ulrey R; Williams KM; Hanley PJ
• Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation
  Volume: 132
  11/29/2018 Authors: Schmidt SA; Chakrabarty JH; Liu Y; Hu Z-H; Williams KM; Alyea EP; Popat U; Sobecks R; Scott BL; Saber W
• The Importance of A, B, Cs! Airways and Breathing Matter for Survival after Hematopoietic Stem Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 24 Page(s): e3 - e4
  11/01/2018 Authors: Williams KM
• Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.
  Blood Adv Volume: 2 Page(s): 1198 - 1206
  06/12/2018 Authors: Harris AC; Boelens JJ; Ahn KW; Fei M; Abraham A; Artz A; Dvorak C; Frangoul H; Freytes C; Gale RP
• Immunogenicity of HPV Quadrivalent Vaccine in Women after Allogeneic HCT is Comparable to Healthy Volunteers
  Volume: 24 Page(s): S73 - S74
  03/01/2018 Authors: Stratton P; Battiwalla M; Abdelazim S; Barrett AJ; Cantilena CR; Childs RW; Fitzhugh C; Fowler DH; Gress RE; Hickstein D
• Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger
  Volume: 24 Page(s): S98 - S100
  03/01/2018 Authors: Zinter MS; Logan BR; Zhu X; Sapru A; Abraham A; Aljurf MD; Arnold SD; Artz A; Auletta JJ; Chhabra S
• Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study.
  Lancet Haematol Volume: 5 Page(s): e44 - e52
  01/01/2018 Authors: Williams KM; Holter-Chakrabarty J; Lindenberg L; Duong Q; Vesely SK; Nguyen CT; Havlicek JP; Kurdziel K; Gea-Banacloche J; Lin FI
• Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients After HCT
  Volume: 64 Page(s): S137 - S137
  11/01/2017 Authors: Williams K; Grant M; Ismail M; Hoq F; Manso MM; Hoover J; Mintz E; Namata A; Williams E; Barese C
• FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche.
  Exp Hematol Volume: 52 Page(s): 40 - 49
  08/01/2017 Authors: Williams KM; Moore AR; Lucas PJ; Wang J; Bare CV; Gress RE
• INFUSION OF DONOR LYMPHOCYTES SPECIFICALLY DIRECTED TO MULTIPLE TUMOR ANTIGENS FOR THE TREATMENT OF HIGH RISK PATIENTS AFTER HCT
  Volume: 19 Page(s): S48 - S48
  05/01/2017 Authors: Williams KM; Grant M; Ismail M; Hoq F; Martin-Manso M; Hoover J; Mintz K; Namata A; Williams E; Barese C
• Voriconazole Levels Indicate That Pediatric Prophylaxis Dosing May be Insufficient
  Volume: 23 Page(s): S176 - S177
  03/01/2017 Authors: Dave H; Hanisch B; Mukherjee R; Jacobsohn DA; Williams D; Bollard CM; Williams KM
• Infusion of Donor Lymphocytes Specifically Directed to Multiple Tumor Antigens for the Treatment of High Risk Patients after HCT
  Volume: 23 Page(s): S34 - S34
  03/01/2017 Authors: Williams KM; Grant M; Ismail M; Hoq F; Manso MM; Hoover J; Mintz EK; Namata A; Williams E; Barese C
• How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
  Blood Volume: 129 Page(s): 448 - 455
  01/26/2017 Authors: Williams KM
• Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children
  Volume: 128
  12/02/2016 Authors: Harris AC; Boelens JJ; Ahn KW; Fei M; Abraham A; Artz A; Dvorak CC; Frangoul H; Freytes CO; Gale RP
• Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
  Ann Am Thorac Soc Volume: 13 Page(s): 1932 - 1939
  11/01/2016 Authors: Cheng G-S; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L
• Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 22 Page(s): 1636 - 1645
  09/01/2016 Authors: Ballen K; Woo Ahn K; Chen M; Abdel-Azim H; Ahmed I; Aljurf M; Antin J; Bhatt AS; Boeckh M; Chen G
• AN AUTOMATIC 3D CT/PET SEGMENTATION FRAMEWORK FOR BONE MARROW PROLIFERATION ASSESSMENT.
  Proc Int Conf Image Proc Volume: 2016 Page(s): 4126 - 4130
  09/01/2016 Authors: Nguyen C; Havlicek J; Duong Q; Vesely S; Gress R; Lindenberg L; Choyke P; Chakrabarty JH; Williams K
• Fluticasone, Azithromycin, and Montelukast Treatment forNew-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 22 Page(s): 710 - 716
  04/01/2016 Authors: Williams KM; Cheng G-S; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S
• ADOPTIVE T CELL IMMUNOTHERAPY FOR TREATMENT OF VIRAL INFECTIONS IN PRIMARY IMMUNODEFICIENCY
  Volume: 36 Page(s): 255 - 255
  04/01/2016 Authors: Keller MD; Hanley PJ; McCormack S; Lang H; Barese C; Abraham A; Jacobsohn D; Perez-Albuerne E; Williams KM; Adams RH
• The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.
  Bone Marrow Transplant Volume: 51 Page(s): 573 - 580
  04/01/2016 Authors: Williams KM; Ahn KW; Chen M; Aljurf MD; Agwu AL; Chen AR; Walsh TJ; Szabolcs P; Boeckh MJ; Auletta JJ
• Novel PET Imaging with Fluorothymidine (FLT) Predicts Relapse Quantitatively at Day 28 Post Transplantation in Patients with Acute Leukemia
  Volume: 22 Page(s): S213 - S214
  03/01/2016 Authors: Williams KM; Holter-Chakrabarty JL; Lindenberg L; Adler S; Chai A; Kurdziel K; Lin F; Blacklock-Schuver BAJ; Avila D; Kanakry CG
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 1167 - 1187
  07/01/2015 Authors: Carpenter PA; Kitko CL; Elad S; Flowers MED; Gea-Banacloche JC; Halter JP; Hoodin F; Johnston L; Lawitschka A; McDonald GB
• The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 1251 - 1257
  07/01/2015 Authors: Holter-Chakrabarty JL; Pierson N; Zhang M-J; Zhu X; Akpek G; Aljurf MD; Artz AS; Baron F; Bredeson CN; Dvorak CC
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 389 - 401.e1
  03/01/2015 Authors: Jagasia MH; Greinix HT; Arora M; Williams KM; Wolff D; Cowen EW; Palmer J; Weisdorf D; Treister NS; Cheng G-S
• Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
  JAMA Volume: 313 Page(s): 594 - 602
  02/10/2015 Authors: Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
• A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
  Volume: 21 Page(s): S248 - S249
  02/01/2015 Authors: Dioguardi J; Bryson E; Ahmed-Winston S; Vaughn G; Slater S; Driscoll J; Perez-Albuerne E; Williams KM
• Malnutrition in patients with chronic GVHD.
  Bone Marrow Transplant Volume: 49 Page(s): 1300 - 1306
  10/01/2014 Authors: Bassim CW; Fassil H; Dobbin M; Steinberg SM; Baird K; Cole K; Joe G; Comis LE; Mitchell SA; Grkovic L
• NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
  Bone Marrow Transplant Volume: 49 Page(s): 561 - 566
  04/01/2014 Authors: Williams KM; Hnatiuk O; Mitchell SA; Baird K; Gadalla SM; Steinberg SM; Shelhamer J; Carpenter A; Avila D; Taylor T
• Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
  Biol Blood Marrow Transplant Volume: 20 Page(s): 337 - 344
  03/01/2014 Authors: Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA
• Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure Syndromes
  Volume: 20 Page(s): S33 - S34
  02/01/2014 Authors: Gadalla S; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
• Cibmtr Retrospective Analysis Reveals Incidence, Mortality, and Timing of Pneumocystis Jiroveci Pneumonia (PCP) after Hematopoietic Stem Cell Transplantation (HSCT)
  Volume: 20 Page(s): S94 - S94
  02/01/2014 Authors: Williams KM; Agwu AG; Chen M; Ahn KW; Szabolcs P; Boeckh MJ; Auletta JJ; Tomblyn MR
• Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
  Bone Marrow Transplant Volume: 49 Page(s): 116 - 121
  01/01/2014 Authors: Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Cole K
• Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
  Biol Blood Marrow Transplant Volume: 19 Page(s): 1238 - 1243
  08/01/2013 Authors: Gadalla SM; Sales-Bonfim C; Carreras J; Alter BP; Antin JH; Ayas M; Bodhi P; Davis J; Davies SM; Deconinck E
• Sensitive GC-MS/MS method to measure deuterium labeled deoxyadenosine in DNA from limited mouse cell populations.
  Anal Chem Volume: 85 Page(s): 4613 - 4620
  05/07/2013 Authors: Farthing DE; Buxbaum NP; Bare CV; Treadwell SM; Kapoor V; Williams KM; Gress RE
• National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
  Biol Blood Marrow Transplant Volume: 19 Page(s): 632 - 639
  04/01/2013 Authors: Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW
• Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
  Volume: 19 Page(s): S143 - S143
  02/01/2013 Authors: Williams KM; Pavletic SZ; Lee SJ; Cottle-Delisle C; Hakim F; Manning-Geiss B; Mitchell S; Gea-Banacloche J; Comis L; Cowen EW
• Oral chronic graft-vs.-host disease characterization using the NIH scale.
  J Dent Res Volume: 91 Page(s): 45S - 51S
  07/01/2012 Authors: Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT
• Immunohistochemistry of affected tissue may guide cGVHD treatment decisions.
  Bone Marrow Transplant Volume: 47 Page(s): 731 - 733
  05/01/2012 Authors: Williams KM; Ostrow LW; Loeb DM; Chung T; Cohn RD; Corse AM; Mammen AL; Chen AR
• Preliminary results of a phase II trial of montelukast for the treatment of Bronchiolitis obliterans syndrome after HSCT and implications for immunobiology of disease
  Volume: 47 Page(s): S61 - S61
  04/01/2012 Authors: Williams K; Pavletic S; Lee S; Hakim F; Mitchell S; Manning-Geist BL; Gea-Banacloche J; Comis L; Cowen E; Baird K
• NIH lung score components are associated with clinical outcomes, Bronchiolitis obliterans syndrome and survival in chronic GvHD
  Volume: 47 Page(s): S61 - S61
  04/01/2012 Authors: Grkovic L; Pulanic D; Steinberg SM; Williams KM; Baird K; Mitchell SA; Cowen EW; Datiles MB; Aria D; Bassim C
• Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.
  Leukemia Volume: 26 Page(s): 633 - 643
  04/01/2012 Authors: Grkovic L; Baird K; Steinberg SM; Williams KM; Pulanic D; Cowen EW; Mitchell SA; Hakim FT; Martires KJ; Avila DN
• SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE IS ASSOCIATED WITH IMPAIRED THYMOPOIESIS AND PERIPHERAL LYMPHOCYTE EXPANSION
  Volume: 18 Page(s): S364 - S365
  02/01/2012 Authors: Buxbaum NP; Williams KM; Amarnath S; Treadwell S; Eckhaus M; Gress RE
• PRELIMINARY RESULTS OF A PHASE II TRIAL OF MONTELUKAST FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AFTER HSCT
  Volume: 18 Page(s): S362 - S362
  02/01/2012 Authors: Williams KM; Pavletic SZ; Hakim FT; Mitchell SA; Gea-Banacloche JC; Comis L; Cowen EW; Baird K; Shelhamer JH; Blacklock-Schuver BAJ
• Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes
  Volume: 118 Page(s): 1739 - 1740
  11/18/2011 Authors: Grkovic L; Mitchell SA; Baird K; Steinberg SM; Cowen EW; Williams KM; Datiles MB; Aria D; Bassim C; Joe G
• Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.
  Blood Volume: 118 Page(s): 4250 - 4257
  10/13/2011 Authors: Martires KJ; Baird K; Steinberg SM; Grkovic L; Joe GO; Williams KM; Mitchell SA; Datiles M; Hakim FT; Pavletic SZ
• Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
  Bone Marrow Transplant Volume: 46 Page(s): 1369 - 1373
  10/01/2011 Authors: Norman BC; Jacobsohn DA; Williams KM; Au BKC; Au MA; Lee SJ; Moravec CK; Chien JW
• Clinical and laboratory markers of sclerotic-type chronic graft versus host disease
  Volume: 131 Page(s): S3 - S3
  04/01/2011 Authors: Martires KI; Baird K; Steinberg SM; Grkovic L; Williams K; Hakim F; Pavletic SZ; Cowen EW
• NHANES III EQUATIONS FOR PFT INTERPRETATION SIGNIFICANTLY ALTERS BOS DIAGNOSES, SEVERITY, AND PROGNOSIS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
  Volume: 17 Page(s): S331 - S331
  02/01/2011 Authors: Williams KM; Hnatiuk O; Steinberg SM; Mitchell S; Baird K; Gadalla SM; Carpenter A; Avila D; Taylor T; Urban A
• IMPAIRED THYMOPOIESIS WITH NORMAL T REGULATORY CELL NUMBERS IS ASSOCIATED WITH SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE
  Volume: 17 Page(s): S341 - S342
  02/01/2011 Authors: Buxbaum NP; Williams KM; Treadwell S; Amarnath S; Eckhans M; Gress RE
• FLT-3 LIGAND ENHANCES THYMOPOIESIS IN HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) INVOLVING AGED DONOR AND RECIPIENT MICE BY INCREASING SURVIVAL AND TRAFFICKING OF EARLY THYMOCYTE PROGENITORS
  Volume: 17 Page(s): S236 - S236
  02/01/2011 Authors: Williams KM; Moore AR; Gress RE
• VALIDATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) CONSENSUS CRITERIA FOR CHRONIC GVHD (cGVHD) STAGING CORRELATED WITH ESTABLISHED INDICATORS OF DISEASE SEVERITY AND PROGNOSIS
  Volume: 17 Page(s): S160 - S161
  02/01/2011 Authors: Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles M; Fall-Dickson JM; Carpenter A
• ROLE OF CLINICAL LABORATORY MARKERS OF INFLAMMATION IN ASSESSING CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD) ACTIVITY AND SEVERITY
  Volume: 17 Page(s): S340 - S341
  02/01/2011 Authors: Grkovic L; Baird K; Steinberg SM; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Carpenter AE; Wroblewski SG; Hakim FT
• Preliminary results of a phase II trial of montelukast for the treatment of bronchiolitis obliterans syndrome after HSCT
  Volume: 45 Page(s): S48 - S48
  03/01/2010 Authors: Williams K; Pavletic S; Hnatiuk O; Hakim F; Mitchell S; Gea-Banacloche J; Comis L; Cowen E; Baird K; Louie A
• PRELIMINARY RESULTS OF A PHASE II TRIAL OF MONTELUKAST FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AFTER HSCT
  Volume: 16 Page(s): S310 - S311
  02/01/2010 Authors: Williams KM; Pavletic SZ; Hakim FT; Mitchell SA; Gea-Banacloche JC; Comis LE; Cowen EW; Baird K; Louie A; Shelhamer JH
• FLT-3 LIGAND AND ANDROGEN WITHDRAWAL ENHANCE IMMUNE RECONSTITUTION AFTER HSCT
  Volume: 16 Page(s): S219 - S219
  02/01/2010 Authors: Williams KM; Moore AR; Gress RE
• Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation
  Page(s): 545 - 564
  01/01/2010 Authors: Williams KM; Gress RE
• Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
  Biol Blood Marrow Transplant Volume: 16 Page(s): S106 - S114
  01/01/2010 Authors: Chien JW; Duncan S; Williams KM; Pavletic SZ
• A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.
  J Pediatr Hematol Oncol Volume: 31 Page(s): 825 - 831
  11/01/2009 Authors: Williams KM; Agwu AL; Dabb AA; Higman MA; Loeb DM; Valsamakis A; Chen AR
• Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury.
  Clin Transl Sci Volume: 2 Page(s): 279 - 285
  08/01/2009 Authors: Williams KM; Mella H; Lucas PJ; Williams JA; Telford W; Gress RE
• Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
  JAMA Volume: 302 Page(s): 306 - 314
  07/15/2009 Authors: Williams KM; Chien JW; Gladwin MT; Pavletic SZ
• AMENDING NIH CONSENSUS CRITERIA FOR THE CLINICAL DIAGNOSIS OF BRONCHIOLITIS OBLITERANS AFTER HSCT
  Volume: 15 Page(s): 125 - 125
  02/01/2009 Authors: Williams KM; Gladwin MT; Chien JW; Louie A; Baird K; Shelhamer JH; Blacklock-Schuver BAJ; Avila D; Mitchell S; Krumlauf M
• CCL25 increases thymopoiesis after androgen withdrawal.
  Blood Volume: 112 Page(s): 3255 - 3263
  10/15/2008 Authors: Williams KM; Lucas PJ; Bare CV; Wang J; Chu Y-W; Tayler E; Kapoor V; Gress RE
• Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
  Pediatr Blood Cancer Volume: 50 Page(s): 667 - 670
  03/01/2008 Authors: Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
• T cell immune reconstitution following lymphodepletion.
  Semin Immunol Volume: 19 Page(s): 318 - 330
  10/01/2007 Authors: Williams KM; Hakim FT; Gress RE
• Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer.
  Front Biosci Volume: 12 Page(s): 4957 - 4971
  09/01/2007 Authors: Aragon-Ching JB; Williams KM; Gulley JL